Authors:
Frebourg, T
Ebel, A
Bonaiti-Pellie, C
Brugieres, L
Berthet, P
Bressac-De Paillerets, B
Chevrier, A
Chompret, A
Cohen-Haguenauer, O
Delattre, O
Feingold, J
Feunteun, J
Frappaz, D
Fricker, JP
Gesta, P
Jonveaux, P
Kalifa, C
Lasset, C
Leheup, B
Limacher, JM
Longy, M
Nogues, C
Oppenheim, D
Sommelet, D
Soubrier, F
Stoll, C
Stoppa-Lyonnet, D
Tristant, H
Citation: T. Frebourg et al., Li-Fraumeni syndrome: update, new data and guidelines for clinical management, B CANCER, 88(6), 2001, pp. 581-587
Authors:
Le Page, F
Randrianarison, V
Marot, D
Cabannes, J
Perricaudet, M
Feunteun, J
Sarasin, A
Citation: F. Le Page et al., BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells, CANCER RES, 60(19), 2000, pp. 5548-5552
Authors:
Chompret, A
Brugieres, L
Ronsin, M
Gardes, M
Dessarps-Freichey, F
Abel, A
Hua, D
Ligot, L
Dondon, MG
Bressac-de Paillerets, B
Frebourg, T
Lemerle, J
Bonaiti-Pellie, C
Feunteun, J
Citation: A. Chompret et al., p53 germline mutations in childhood cancers and cancer risk for carrier individuals, BR J CANC, 82(12), 2000, pp. 1932-1937
Citation: J. Feunteun, Hereditary predisposition to breast and ovarian cancer linked to BRCA1 andBRCA2: a disease of the genotoxic damage repair processes, M S-MED SCI, 15(1), 1999, pp. 38-44
Authors:
Devilee, P
Barkardottir, RB
Bevilacqua, G
Bignon, YJ
Bishop, T
Borg, A
Borresen-Dale, AL
Chang-Claude, J
Easton, D
Eyfjord, J
Feunteun, J
Goldgar, D
Haites, N
Holm, N
Kruse, T
Larsson, C
Lenoir, G
Lidereau, R
Nevanlinna, H
Ponder, B
Scherneck, S
Schmitt, F
Sobol, H
Solomon, E
Spurr, N
Steel, M
Stratton, M
Varley, J
Vasen, H
Vassilaros, S
Wagner, T
Willems, P
Winqvist, R
Citation: P. Devilee et al., Genetics and epidemiology of hereditary breast cancer, BIOM HLTH R, 24, 1998, pp. 339-346
Authors:
Chatelut, M
Caspar-Bauguil, S
Tkaczuk, J
Alibaud, L
Pieraggi, MT
Roudani, S
Vacaresse, N
Feunteun, J
Laharrague, P
Duchayne, E
Demur, C
Vincent, MC
Thiers, JC
Salvayre, R
Levade, T
Citation: M. Chatelut et al., Establishment and characterization of a human T-lymphocyte cell line immortalized by SV40 and with abnormal expression of TCR/CD3, SC J IMMUN, 48(6), 1998, pp. 659-666
Authors:
Pasini, A
Chappuis-Flament, S
Geneste, O
Fournier, L
Schuffenecker, I
Michiels, FM
Feunteun, J
Pelet, A
Lyonnet, S
De Vita, G
Santoro, M
Lenoir, GM
Giraud, S
Billaud, M
Citation: A. Pasini et al., RET, hereditary cancers and congenital malformation: A deregulation model of a tyrosine kinase receptor in human pathology, EUROCANCER 98, 1998, pp. 95-96